News | February 12, 2008

CAD Increases Diagnostic Accuracy by 44 Percent, Study Shows

February 13, 2008 - A study has found that Medipattern's B-CAD 2, a computer-assisted detection program, increased the diagnostic accuracy up to 44 percent on lesions less than 1 cm in size, according to Medipattern Corp.

B-CAD v2 is only available outside the U.S.

The study was conducted at the PLA301 Hospital in Beijing, China and was based upon 100 confirmed biopsied cases, comparing the diagnostic accuracy of three reading scenarios: a single physician, double reading with two physicians and a single physician reading with B-CAD. The accuracy of the single physician increased with B-CAD in all categories. According to Medipattern, the most striking result showed a 44 percent improvement in diagnostic accuracy for the single reader with B-CAD v2 on lesions less than 1 cm in size.

The physicians were not aware of the pathology outcomes when reading. The cases were separated into three size categories, malignant cancers greater than 2 cm, ranging from 1 to 2 cm and less than 1 cm. The cases were evaluated using the American College of Radiology (ACR) Breast Imaging Reporting and Data System (BI-RADS) Lexicon. Doctors reading without B-CAD used the lexicon to characterize the lesions in the study and assess the diagnosis. B-CAD automatically finds the edge of the lesion and uses this information to characterize the lesion for the physician. B-CAD further consolidates the information into a detailed report documenting whether the lesion is probably benign or probably malignant.

For more information: www.medipattern.com

Related Content

MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform
Technology | Artificial Intelligence | November 07, 2018
MaxQ AI announced that its Accipio Ix intracranial hemorrhage (ICH) detection software has received 510(k) clearance...
iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
SimonMed Deploys ClearRead CT Enterprise Wide
News | Computer-Aided Detection Software | September 17, 2018
September 17, 2018 — National outpatient physician radiology group SimonMed Imaging has selected Riverain Technologie
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
FDA Issues Proposed Order to Reclassify Certain Radiological Medical Image Analyzers
News | Computer-Aided Detection Software | June 01, 2018
The U.S. Food and Drug Administration (FDA) is issuing a proposed order to reclassify certain radiological medical...
Median Technologies and the Nice University Hospital to Use AI in Lung Cancer Screening
News | Artificial Intelligence | March 15, 2018
March 15, 2018 – Median Technologies, the industry-leading Imaging Phenomics Company and the Nice University Hospital
FDA Clears First AI-Powered Clinical Decision Support Software for Stroke
Technology | Clinical Decision Support | February 14, 2018
The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact application, the first ...
Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...